Retail Drug License in India — Forms, Process, and the Mistakes Even Compliance Blogs Make

Search "drug license form 20 vs form 21" and you'll find at least three well-ranked compliance-vendor articles that get the mapping backwards — describing Form 20-B as a "restricted retail" license and Form 21 as a wholesale form. It isn't. We pulled the actual rule text from the Drugs and Cosmetics Rules, 1945 to get this right, because a pharmacist relying on the wrong form during a state FDA application loses weeks, not minutes.

What each form actually covers (Rule 61)

The two errors we found repeated across multiple sites: Form 20-B is wholesale, not a stricter retail tier, and Form 21 is retail, not wholesale. If your pharmacy stocks vaccines, insulin, or other Schedule C/C1 biologicals alongside general medicines, you typically need both Form 20 and Form 21 side by side — not one "upgraded" form.

The application itself is filed on Form 19; what comes back if approved is the license in the relevant Form (20, 20-A, 21, etc.).

Who issues it, and what you actually need

Drug licenses are not issued by a central authority. Each state's Drugs Controller / State Licensing Authority (part of the State FDA or Drugs Control Organisation) handles applications, inspections, and renewals independently — which is also why fees, exact document checklists, and processing time vary meaningfully by state. Anything you read online quoting one fee as if it applies nationwide should be treated with suspicion.

What's consistent across states, directly from the rule text:

• Minimum premises area: 10 square metres for a standalone retail license (commonly cited as 15 sq m where retail and wholesale are combined on the same premises — this can vary by state, confirm with your local Drugs Controller).
• A Registered Pharmacist must be present during all working hours, and sales must occur under their supervision, for the standard Form 20/21 license.
• The pharmacist needs a D.Pharm or B.Pharm from a Pharmacy Council of India–approved institution, plus current registration with their State Pharmacy Council.
• Cold storage (refrigerator) is required for Schedule C/C1 biologicals under Form 21 — vaccines and insulin need documented cold-chain handling, not just a fridge in the back room.

Processing time varies by state and depends on when the inspection happens — there is no statutory deadline, so build in buffer.

Renewal isn't a fresh application. Under Rule 63, licenses are kept current through a retention fee paid every 5 years, not a full re-application from scratch — a detail that trips up first-time owners who assume they'll have to redo the whole process on a schedule.

The Schedule H1 register: what's actually legally required vs. what's good practice

This is where we see the most confusion, including in our own earlier writing. Rule 65(3)(h) of the Drugs and Cosmetics Rules states the supply of a Schedule H1 drug must be recorded with the name and address of the prescriber, the name of the patient, the name of the drug, and the quantity supplied — retained for 3 years and open to inspection. That's the legal floor.

What the H1 sub-clause does not spell out, the rest of Rule 65 does. The same supply must also be recorded — in a prescription register or on a serially numbered cash or credit memo — with the serial number, the date of supply, the prescriber's name and address, the patient's name and address, the drug and quantity, and, for Schedule C, H and H1 drugs, the manufacturer, batch number and expiry, signed by the registered pharmacist. So batch number, date and the patient's address are statutory, through that general record. The prescriber's registration number and the patient's age are good practice on top, and we'd still recommend logging them. Just don't mistake "recommended" for "the law" — or the law for "recommended" — since conflating the two is exactly the kind of overclaim that erodes trust with a pharmacist who's already dealt with an inspector once.

Schedule H1 itself was created by the Drugs and Cosmetics (Fourth Amendment) Rules, 2013, and covers categories including certain third- and fourth-generation antibiotics, anti-tuberculosis drugs, and select habit-forming/psychotropic drugs (alprazolam is H1, not plain Schedule H, which surprises a lot of people). We're not going to quote you an exact molecule count for the current list — different sources cite different totals, and we'd rather point you to your state's official Schedule H1 list than repeat an unverified number.

Where NDPS actually applies to a normal retail counter

Most retail pharmacies never touch the Narcotic Drugs and Psychotropic Substances Act, 1985 directly — bulk narcotics require separate licensing that ordinary chemists don't hold or need. The place it does intersect with everyday retail: a handful of Schedule H1 drugs (alprazolam and some opioid-agonist formulations) are simultaneously classified as psychotropic substances under NDPS. For these, your Schedule H1 register covers part of the documentation burden — but check with your State Drug Control office on whether any additional state-specific stock register or possession-limit rule applies, since this genuinely varies by state and isn't something we'll pretend has one national answer.

One recent change worth knowing about

The Jan Vishwas (Amendment of Provisions) Act, 2023, with pharmacist-specific rules notified by the Pharmacy Council of India on 13 June 2025, converted several Pharmacy Act offences — falsely claiming to be a registered pharmacist, dispensing without registration, obstructing an inspector — from imprisonment to a monetary penalty (up to ₹1 lakh). This is a penalty-structure change, not a relaxation of who's allowed to be a pharmacist-in-charge — worth knowing, easy to misread as the latter.

FAQ

Do I need both Form 20 and Form 21 for a normal pharmacy?

Only if you stock Schedule C/C1 biologicals (vaccines, insulin, hormone products) alongside general medicines. A pharmacy selling only general Schedule-H/H1 drugs needs Form 20 alone. Most full-service retail pharmacies end up holding both.

How much does a drug license actually cost?

There's no single national fee — each state sets its own, and filing Form 20 and Form 21 separately can cost more than a combined application. Check your State Drug Control Department's portal directly for your state's number.

Do I need to reapply for my license every few years?

No. Under Rule 63, you pay a retention fee every 5 years to keep the license current — it isn't a fresh application each time.

Is the Schedule H1 register the same as a general prescription register?

Related but not identical. The H1-specific requirement under Rule 65(3)(h) is narrower (prescriber name/address, patient name, drug, quantity, 3-year retention). The general record of every supply under Rule 65 asks for more — including the patient's address and, for Schedule C, H and H1 drugs, the manufacturer, batch number and expiry.

Can software handle Schedule H1 logging for me?

Partly — this is a structured, rule-based record (not something requiring judgment), so software can capture most of it at the point of sale. Nesayo logs every Schedule H1 sale at billing: the date, medicine, batch, quantity and bill number, with the patient and prescriber names entered on the bill. Nesayo does not record the prescriber's address yet, and it does not print or export the register, so the pharmacist adds the address to complete the Rule 65(3)(h) register.

Sources

• Rule 61, Drugs and Cosmetics Rules 1945 — Indian Kanoon
• Rule 63, Drugs and Cosmetics Rules 1945 — Indian Kanoon
• Rule 65(3), Drugs and Cosmetics Rules 1945 — Indian Kanoon
• Delhi Department of Drugs Control — official licensing procedure
• Pharmacy Council of India — Jan Vishwas Act rules notified 13 June 2025

Last reviewed: 2026-08-22. Fees, forms, and area requirements are set at the state level and change — always confirm directly with your State Drugs Controller before applying.